This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Asthma and Lung UK | |
Formation | January 1, 2020 |
---|---|
Merger of | Asthma UK British Lung Foundation |
Type | Charitable organisation |
Registration no. |
|
Purpose | Health policy |
Headquarters | The White Chapel Building, 10 Whitechapel High Street, London, E1 8QS |
Coordinates | 51°30′52″N0°04′22″W / 51.5145°N 0.0728°W |
Patron | The Duchess of Gloucester |
Key people | Sarah Sleet (CEO) Tamara Ingram (Chair) Professor Ian Hall (Vice Chair) |
Revenue (2022/23) | £15 million [1] |
Employees (2023) | 300 [1] |
Volunteers (2023) | 179 [1] |
Website | https://www.asthmaandlung.org.uk/ |
Formerly called | Asthma UK and British Lung Foundation Partnership |
Asthma + Lung UK (formally Asthma and Lung UK) is a British charity based in London, England. It focuses on respiratory health, in particular asthma and lung disease. [2] [3]
The organisation was formed in January 2020 as Asthma UK and the British Lung Foundation Partnership as a result of a merger between Asthma UK and the British Lung Foundation. [4] [5] On 24 February 2022, the charity announced that the organisation had been renamed to Asthma and Lung UK. [6]
Asthma UK was initially founded in 1927, under the name of the Asthma Research Council. [7] The first donation was used to pay for special asthma clinics at Guy's Hospital and Great Ormond Street Hospital. In 1989, the Council became the National Asthma Campaign, and in 2004, it changed its name to Asthma UK.
Meanwhile, the British Lung Foundation was established by Professor Sir Malcolm Green and a group of British lung specialists in 1984. [8]
In December 2019, Asthma UK and the British Lung Foundation announced that they had agreed to merge, to form Asthma UK and the British Lung Foundation Partnership. It was expected that the merged charity would save around £2 million a year in running costs compared to operating independently. Kay Boycott was appointed as the first chief executive of the partnership having been the incumbent chief executive of Asthma UK at the time of the merger. [4] The British Lung Foundation's records with the Charity Commission and Companies House were renamed and remain in use, while Asthma UK's records were left dormant. [3] [9] [10] [11] On 24 February 2022, the charity announced that the organisation had been renamed to Asthma and Lung UK, styled as Asthma + Lung UK. [6]
Asthma + Lung UK appointed Sarah Sleet as its new chief executive officer in January 2024. [12] She replaced Sarah Woolnough, who had been in post for the previous three years. [13]
Asthma + Lung UK – and its previous incarnations – is known for the research it has been carrying out into asthma and lung disease for the past decades. It has informed a number of parliamentary debates on the issue. [14] [15] [16]
Since 2012, Asthma UK has conducted an annual survey of people with asthma, [17] looking into their experience of living with the condition and the care they receive. [18] [19] [20] The survey has been taken over and continued by Asthma + Lung UK since the merger with the British Lung Foundation. [21]
In 2014, Asthma UK founded the Centre for Applied Research in asthma at University of Edinburgh. [22] The Centre has been a regular participant in the Scottish Parliament's Cross-Party Group on Lung Health since its inception in 2021. [23] [24]
The British Lung Foundation helped found the Taskforce for Lung Health in 2018, [25] which brought together representatives from over 40 organisations in the sector to make recommendations on how to improve care for lung disease in the UK. In 2020, the taskforce revealed that lung patients’ symptoms had improved during lockdown as a result of a drop in air pollution. [26] However in 2021, it warned that one fifth of lung disease patients had to wait more than a year for a prognosis, and risked dying before they were even diagnosed. [27]
In 2023, Asthma + Lung UK published research which suggested up to 750,000 people in England were being misdiagnosed with asthma, due to a lack of simple tests for common lung conditions. [28] [29] The research claimed these misdiagnoses cost the government an estimated £132 million each year.
Research published by the charity in 2024 showed that while deaths from asthma attacks were up by a quarter since 2010, two thirds of asthma deaths were preventable. [30]
In 2021-22, Asthma + Lung UK generated £13.9 million. [31] Of this amount, £5.1m came from legacies (37%), £4.3m from donations (31%), £1.4m from fundraising (10%), £1.3m from grants (9%), £0.5m from gifts in kind (4%), and £0.4m from its investment portfolio (3%).
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.
Royal Brompton Hospital is the largest specialist heart and lung medical centre in the United Kingdom. It is managed by Guy's and St Thomas' NHS Foundation Trust.
Professor Sir Bruce Edward Keogh, KBE, FMedSci, FRCS, FRCP is a Rhodesian-born British surgeon who specialises in cardiac surgery. He was medical director of the National Health Service in England from 2007 and national medical director of the NHS Commissioning Board from 2013 until his retirement early in 2018. He is chair of Birmingham Women's and Children's NHS Foundation Trust and chairman of The Scar Free Foundation.
NHS Scotland, sometimes styled NHSScotland, is the publicly–funded healthcare system in Scotland and one of the four systems that make up the National Health Service in the United Kingdom. It operates 14 territorial NHS boards across Scotland, supported by seven special non-geographic health boards, and Public Health Scotland.
King's College Hospital NHS Foundation Trust is an NHS trust in London, England. It is closely involved with Guy's and St Thomas' NHS Foundation Trust, with which it shares its chair, Sir Hugh Taylor, its strategy director and IT director. It is assumed that the two organisations will eventually merge.
The health of the Scottish population is, and has been for many years, worse than that of the English. Life expectancy is the lowest in the UK, at 77.1 for men and 81.1 for women, and one of the lowest in the OECD. The gap between Scotland and England has grown since 1980. Some of this is clearly attributable to economic disadvantage, but the differences in health status are more pronounced that would be expected on that basis. It has often been suggested that the Scottish diet is to blame. This is particularly so in Glasgow and the Glasgow effect has been the subject of some academic study.
Healthcare in the United Kingdom is a devolved matter, with England, Northern Ireland, Scotland and Wales each having their own systems of publicly funded healthcare, funded by and accountable to separate governments and parliaments, together with smaller private sector and voluntary provision. As a result of each country having different policies and priorities, a variety of differences have developed between these systems since devolution.
The National Health Service (NHS) is the publicly funded healthcare system in England, and one of the four National Health Service systems in the United Kingdom. It is the second largest single-payer healthcare system in the world after the Brazilian Sistema Único de Saúde. Primarily funded by the government from general taxation, and overseen by the Department of Health and Social Care, the NHS provides healthcare to all legal English residents and residents from other regions of the UK, with most services free at the point of use for most people. The NHS also conducts research through the National Institute for Health and Care Research (NIHR).
The National Health Service (NHS) is the umbrella term for the publicly funded healthcare systems of the United Kingdom, comprising the NHS in England, NHS Scotland and NHS Wales. Health and Social Care in Northern Ireland was created separately and is often locally referred to as "the NHS". The original three systems were established in 1948 as part of major social reforms following the Second World War. The founding principles were that services should be comprehensive, universal and free at the point of delivery—a health service based on clinical need, not ability to pay. Each service provides a comprehensive range of health services, provided without charge for people ordinarily resident in the United Kingdom apart from dental treatment and optical care. In England, NHS patients have to pay prescription charges; some, such as those aged over 60, or those on certain state benefits, are exempt.
The Healthcare Quality Improvement Partnership (HQIP) was established in April 2008 to promote improvement in health services, by increasing the impact that clinical audit has on healthcare quality in England and Wales and, in some cases other devolved nations. It is led by a consortium of the Academy of Medical Royal Colleges, Royal College of Nursing and National Voices.
The British Thyroid Foundation (BTF) is a UK-based, patient-led, registered charity dedicated to supporting people with thyroid disorders and helping their families and people around them to understand the condition.
The Canadian Lung Association is a national organization and volunteer-based health charity that supports lung health research, education, prevention of disease/disorders and advocacy in Canada.
Genetic Alliance UK is a national charity and an alliance of over 200 patient organisations, supporting those affected by genetic conditions. Genetic Alliance UK's aim is to improve the lives of people affected by genetic conditions, ensuring that high quality services and information are available to all who need them.
The Royal Foundation of The Prince and Princess of Wales is an independent United Kingdom-based charity which supports the non-profit work of the Prince and Princess of Wales. Their projects revolve around conservation, environmental issues, early childhood development, mental health, emergency services, and homelessness.
The Medical Technology Group (MTG) is a not for profit organisation in the United Kingdom comprising patient groups, research charities and medical device manufacturers. Its stated aim is to "work together to improve patient access to effective medical technologies". The Group launched in 2001.
Mental health in the United Kingdom involves state, private and community sector intervention in mental health issues. One of the first countries to build asylums, the United Kingdom was also one of the first countries to turn away from them as the primary mode of treatment for the mentally ill. The 1960s onwards saw a shift towards Care in the Community, which is a form of deinstitutionalisation. The majority of mental health care is now provided by the National Health Service (NHS), assisted by the private and the voluntary sectors.
Versus Arthritis is the United Kingdom's largest charity dedicated to supporting people with arthritis. It was launched in 2018, following the legal merger of the country's two leading arthritis charities, Arthritis Research UK and Arthritis Care in 2017.
The COVID-19 pandemic in Scotland is part of the COVID-19 pandemic of coronavirus disease-2019, caused by the virus SARS-CoV-2. The first case of COVID-19 was confirmed in Scotland on 1 March 2020. Community transmission was first reported on 11 March 2020, and the first confirmed death was on 13 March 2020.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.